Drug Patent Expirations for May 14, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

CADUET (amlodipine besylate; atorvastatin calcium)
Pfizer
Patent number: 5,686,104
Expiration Date: May 11, 2015


LIPTRUZET (atorvastatin calcium; ezetimibe)
Merck Sharp Dohme
Patent number: 5,686,104
Expiration Date: May 11, 2015


LIPITOR (atorvastatin calcium)
Pfizer
Patent number: 5,686,104
Expiration Date: May 11, 2015


AFREZZA (insulin recombinant human)
Sanofi Aventis
Patent number: 8,394,414
Expiration Date: May 15, 2015


AFREZZA (insulin recombinant human)
Sanofi Aventis
Patent number: 6,071,497
Expiration Date: May 15, 2015


AFREZZA (insulin recombinant human)
Sanofi Aventis
Patent number: 6,428,771
Expiration Date: May 15, 2015


For more information try a free trial


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: